Warby Parker
WRBY NYSE Apparel, Accessories & Luxury Goods Financials FY2019–FY2025
Warby Parker's revenue rose 13.0% to $872 million in fiscal 2025. Its operating margin was −0.6%, up from −3.9% a year earlier. Free cash flow was $44 million, up 26.0%. The diluted share count rose 3.9%.
About these figures. Warby Parker reports no borrowings (its credit line is undrawn), so debt is counted as zero.
What Warby Parker does
No business description yet.
- Legal name
- Warby Parker Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- —
- Accession · CIK
- 0001504776-26-000006
0001504776
Revenue and margins
Warby Parker had $872M of revenue in fiscal 2025, up 13.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $43.7M in fiscal 2025, 5.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Warby Parker returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 3.9%.
Value Warby Parker yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of $286M and divides by 125.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today — · peers 12.8x · sector 17.8x.
Balance sheet
Cash, debt and the ratios that show how comfortably Warby Parker can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $256M | $209M | $217M | $254M | $286M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | — | — | — | −16.1x | −6.4x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | −957.7x | −604.4x | −317.2x | −122.4x | −16.4x |
| Current ratio | 2.8x | 2.3x | 2.4x | 2.5x | 2.4x |
| Quick ratio | 2.3x | 1.7x | 1.9x | 2.1x | 2.1x |
| Total assets | $441M | $569M | $580M | $677M | $721M |
| Total liabilities | $155M | $282M | $279M | $336M | $353M |
| Shareholders' equity | $286M | $287M | $302M | $340M | $368M |
| Net debt (− = net cash) | −$256M | −$209M | −$217M | −$254M | −$286M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$20.9M
6 insiders
Of sales under plans
95%
$19.9M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | David Abraham GilboaCo-Chief Executive Officer, Director | Sold plan | 54,347 | $29.84 | $1.6M | Form 4 |
| Jul 6, 2026 | Neil Harris BlumenthalCo-Chief Executive Officer, Director | Sold plan | 9,200 | $29.99 | $0.3M | Form 4 |
| Jul 1, 2026 | David Abraham GilboaCo-Chief Executive Officer, Director | Sold plan | 242,221 | $29.69 | $7.2M | Form 4 |
| Jul 1, 2026 | Jeffrey Jacob RaiderDirector | Sold plan | 22,500 | $29.72 | $0.7M | Form 4 |
| Jul 1, 2026 | Neil Harris BlumenthalCo-Chief Executive Officer, Director | Sold plan | 217,667 | $29.61 | $6.4M | Form 4 |
| Jun 29, 2026 | Neil Harris BlumenthalCo-Chief Executive Officer, Director | Sold plan | 36,300 | $30.04 | $1.1M | Form 4 |
| Jun 16, 2026 | Teresa BriggsDirector | Sold plan | 5,000 | $25.94 | $0.1M | Form 4 |
| Jun 12, 2026 | Youngme E MoonDirector | Sold | 10,000 | $26.53 | $0.3M | Form 4 |
| May 19, 2026 | Neil Harris BlumenthalCo-Chief Executive Officer, Director | Sold plan | 63,040 | $30.03 | $1.9M | Form 4 |
| May 14, 2026 | Bradley E SingerDirector | Sold | 4,833 | $29.01 | $0.1M | Form 4 |
| May 13, 2026 | Bradley E SingerDirector | Sold | 20,167 | $28.51 | $0.6M | Form 4 |
| Apr 20, 2026 | Neil Harris BlumenthalCo-Chief Executive Officer, Director | Sold plan | 22,442 | $25.09 | $0.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✕ | ✕ | ✕ |
| Current ratio rose | ✓ | ✓ | ✕ |
| Share count didn't rise | ✕ | ✕ | ✕ |
| Gross margin rose | ✕ | ✓ | ✕ |
| Revenue rose relative to assets | ✕ | ✓ | ✕ |
| F-score | 4 / 9 | 6 / 9 | 4 / 9 |
| Accruals ratio | −21.6% | −19.0% | −15.6% |
| Altman Z'' | −1.50 | −0.65 | −0.22 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Warby Parker WRBY | $3.3B | 13.0% | −0.6% | 5.0% | −3.4% | — | 4 | |
| Carter's CRI | $1.2B | 1.9% | 5.0% | 2.4% | 11.9% | 6.1x | 5 | Compare → |
| G-III Apparel Group GIII | $1.3B | −7.0% | 3.7% | 8.9% | 4.6% | 9.7x | 6 | Compare → |
| Kontoor Brands KTB | $4.2B | 20.9% | 10.7% | 13.8% | 21.2% | 15.9x | 6 | Compare → |
| Columbia Sportswear COLM | $3.1B | 0.9% | 6.1% | 6.4% | 17.0% | 16.0x | 5 | Compare → |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $371M | $394M | $541M | $598M | $670M | $771M | $872M |
| Gross profit | $223M | $232M | $318M | $341M | $365M | $427M | $471M |
| Operating income | −$1.7M | −$55.6M | −$144M | −$111M | −$72.0M | −$30.1M | −$5.3M |
| Interest expense | $0.1M | $0.5M | $0.1M | $0.2M | $0.2M | $0.2M | $0.3M |
| Pretax income | $0.3M | −$55.7M | −$144M | −$110M | −$62.8M | −$19.5M | $3.0M |
| Income tax | $0.3M | $0.2M | $0.3M | $0.5M | $0.4M | $0.9M | $1.4M |
| Net income | $0.0M | −$55.9M | −$144M | −$110M | −$63.2M | −$20.4M | $1.6M |
| Diluted EPS | −$1.10 | −$1.05 | −$2.21 | −$0.96 | −$0.54 | −$0.17 | $0.01 |
| Diluted shares | 0.05B | 0.05B | 0.07B | 0.11B | 0.12B | 0.12B | 0.13B |
| Cash flow | |||||||
| Cash from operations | $21.4M | $32.8M | −$32.0M | $10.4M | $61.0M | $98.7M | $111M |
| Capital expenditure | $32.6M | $20.1M | $48.5M | $60.2M | $53.7M | $64.0M | $67.0M |
| Free cash flow | −$11.2M | $12.7M | −$80.5M | −$49.8M | $7.3M | $34.7M | $43.7M |
| Depreciation and amortization | $14.5M | $17.8M | $21.6M | $31.9M | $38.6M | $45.9M | $50.3M |
| Stock-based compensation | $8.5M | $44.9M | $107M | $98.0M | $70.5M | $47.3M | $34.5M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $79.5M | $0.0M | $8.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $79.5M | $0.0M | $8.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $55.4M | $314M | $256M | $209M | $217M | $254M | $286M |
| Total debt | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | — | $360M | $328M | $295M | $299M | $326M | $352M |
| Current liabilities | — | $105M | $118M | $130M | $127M | $130M | $150M |
| Inventory | $0.0M | $38.5M | $57.1M | $68.8M | $62.2M | $52.3M | $44.5M |
| Property and equipment, net | — | $84.5M | $112M | $139M | $152M | $171M | $187M |
| Total assets | — | $445M | $441M | $569M | $580M | $677M | $721M |
| Total liabilities | — | $136M | $155M | $282M | $279M | $336M | $353M |
| Shareholders' equity | −$190M | −$198M | $286M | $287M | $302M | $340M | $368M |
| Margins | |||||||
| Gross margin | 60.2% | 58.9% | 58.8% | 57.0% | 54.5% | 55.3% | 54.0% |
| Operating margin | −0.5% | −14.1% | −26.6% | −18.6% | −10.8% | −3.9% | −0.6% |
| EBITDA margin | 3.5% | −9.6% | −22.6% | −13.3% | −5.0% | 2.0% | 5.2% |
| Net margin | 0.0% | −14.2% | −26.7% | −18.5% | −9.4% | −2.6% | 0.2% |
| FCF margin | −3.0% | 3.2% | −14.9% | −8.3% | 1.1% | 4.5% | 5.0% |
| Returns | |||||||
| Return on capital | — | — | — | −163.2% | −69.8% | −27.9% | −3.4% |
| Return on capital employed | — | — | −43.4% | −29.2% | −16.1% | −6.0% | −1.0% |
| Return on equity | — | — | −328.3% | −38.6% | −21.5% | −6.4% | 0.5% |
| Return on assets | — | — | −32.6% | −21.9% | −11.0% | −3.2% | 0.2% |
| Growth | |||||||
| Revenue growth | — | 6.3% | 37.4% | 10.6% | 12.0% | 15.2% | 13.0% |
| FCF growth | — | — | −734.5% | — | — | 374.2% | 26.0% |
| Share count change | — | 1.2% | 34.4% | 61.3% | 2.1% | 2.6% | 3.9% |
| Financial health | |||||||
| Net debt / EBITDA | −4.3x | — | — | — | — | −16.1x | −6.4x |
| Debt / equity | — | — | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | −18.9x | −119.4x | −957.7x | −604.4x | −317.2x | −122.4x | −16.4x |
| Current ratio | — | 3.4x | 2.8x | 2.3x | 2.4x | 2.5x | 2.4x |
| Quick ratio | — | 3.1x | 2.3x | 1.7x | 1.9x | 2.1x | 2.1x |
| Capital allocation | |||||||
| Capex / revenue | 8.8% | 5.1% | 9.0% | 10.1% | 8.0% | 8.3% | 7.7% |
| Stock comp / revenue | 2.3% | 11.4% | 19.8% | 16.4% | 10.5% | 6.1% | 4.0% |
| Payouts / FCF | — | 0.0% | — | — | 0.0% | 0.0% | 0.0% |
| Quality scores | |||||||
| Piotroski F-score | — | — | — | 4.0 | 4.0 | 6.0 | 4.0 |
| Altman Z'' | — | −1.0 | −0.8 | −1.8 | −1.5 | −0.7 | −0.2 |
| Accruals ratio | — | — | −25.4% | −23.9% | −21.6% | −19.0% | −15.6% |
Source: SEC EDGAR XBRL filings (CIK 0001504776). Data updated October 12, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.